Recruiting · registry status

A traditional herbal preparation early in Parkinson's

This study tests Shengyang Yiwei granules alongside usual treatment. Benefits remain to be established.

Testing a treatment or activity · Study reference: ChiCTR1900025894

Plain-language introduction written with AI from the registry; not independently checked by a clinician. Read the original details below ↓

This registry record was last updated over six months ago, or its update date is missing. Recruitment may have changed. Confirm with the team before making plans.

Open the official registry record ↗

Follow this study

Looking for volunteers

Start (reported date): 2019-09-11

Planned dates can move. A study finishing does not tell us when a paper will be published.

No results summary has been confirmed in the registry records we imported. See connected papers below; we keep checking after recruitment ends.

Changes we have recorded

2026-10-11 — recruiting

These are dates we observed a change, not necessarily the dates it happened.

Papers connected to this study

No connected paper has been found yet. The tracker checks the growing library for study identifiers and registry-linked publications.

Who can join?

Age range not listed · Ask the team who can join

These are starting points, not the full rules. The research team can tell you whether the study is right for your situation.

Read all the rules for taking part

Sex eligibility reported by registry: both

Inclusion criteria: (1) Those who meet the diagnostic criteria of PD Chinese and Western medicine; (2) TCM syndrome differentiation belongs to spleen and lung deficiency; (3) Those aged 55-80 years; (4) Modified HY stage <= 2.5; (5) Conscious, vital signs are stable; (6) Those who voluntarily accept this experimental study and informed consent. Exclusion criteria: (1) Parkinson's syndrome and Parkinson's superposition syndrome caused by various causes such as cerebrovascular disease and poisoning; (2) Those with major diseases such as severe liver and kidney, blood, tumor, endocrine disease or pain (3) Those who are involved in other drug clinical trials; (4) Psychiatric patients; (5) Those who have a history of ugly drinking or a history of drug abuse.

Full study name & original research details

Official study title

Parallel randomized controlled trial for Shengyang Yiwei Granule in the treatment of early Parkinson's disease

Original description

Intervention: experimental group:Parkinson's disease routine medication, plus Shengyang Yiwei granules, water blunt, one dose, morning and evening;control group:Parkinson's disease routine medication, add Buzhong Yiqi granules, water blunt, one dose, morning and evening; Primary outcome: Unified Parkinson's Disease Rating Scale (UPDRSI II III);Parkinson's Non-motor syndrome Scale (NMSS);

Conditions reported: parkinson disease

Registry records for this study

Records are joined using registration identifiers. Titles alone do not establish that two studies are the same.

ChiCTR · ChiCTR1900025894 ↗ — Recruiting; WHO ICTRP processed 2019-09-16; checked 2026-10-14
ITMCTR · ITMCTR1900002593 ↗ — Recruiting; WHO ICTRP processed 2023-02-20; checked 2026-10-14

Study type: Interventional
Interventions: experimental group:Parkinson's disease routine medication, plus Shengyang Yiwei granules, water blunt, one dose, morning and evening;control group:Parkinson's disease routine medication, add Buzhong Yiqi granules, water blunt, one dose, morning and evening;
Phases: 0
Sponsor: Kaida Wang
Start date reported by registry: 2019-09-11 (reported)

Registry updated: Not reported · Status last verified by the registry submitter: Not reported

Registry records retrieved 2026-10-14 (UTC). Individual records may have older updates. Recruitment and eligibility must be confirmed with the study team.

Contact the research team

Public study contacts supplied to the registry. Ask whether recruitment is still open and what participation involves.

Kaida Wang · +86 13854115876 · baoyushou3@163.com

Study locations

Site status can differ from overall study status. “Status not reported” means local availability needs confirmation. Remote participation and travel arrangements must be checked with the team.

Facility not reported

China

Status not reported

The original descriptions and participation rules come from the registry. Participation is voluntary and does not guarantee benefit.